Delivery Order SPE2DB20D1109-SPE2DB25FP53Y
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,289.42 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $33,133.71 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $82,826.37 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes, with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes valued at $8,333.09, with an ultimate completion date of April 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,735.28 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes. This firm fixed-price delivery order, issued on August 5, 2025, represents a non-competitive award executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes with a ceiling value of $13,396.25 under a firm fixed price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and the work will be performed in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,948.42 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes. This non-competitive, firm fixed-price delivery order was executed on September 17, 2025, with an ultimate completion date of September 18, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $73,246.58 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes, with a completion date of July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $15,763.91 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the place of performance in Conshohocken, PA. This delivery order represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,615.99 to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes. This firm fixed price delivery order, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive award under an existing contract vehicle. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP53YDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,540.76 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This competitive delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp serves as a primary supplier to military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products, specialty medications, vaccines, syringes, and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical supply chain relationship reflects the company's demonstrated capability to meet federal procurement requirements through competitive open competition and its role in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.5k | 8/7/25 |